Css LLC Abb Vie Inc. Put Options Transaction History

Css LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $1.68 Million - $1.92 Million	-12,500 Reduced 31.25%	27,500 $3.69 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $2 Million - $2.54 Million	-14,500 Reduced 26.61%	40,000 $6.13 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $4.55 Million - $5.65 Million	34,500 Added 172.5%	54,500 $8.84 Million
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $2.05 Million - $2.25 Million	20,000 New	20,000 $2.16 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $733,700 - $981,800	-10,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $1.09 Million - $1.65 Million	-16,900 Reduced 62.83%	10,000 $762,000
Q2 2018 Aug 14, 2018	BUY	$89.78 - $106.23 $2.42 Million - $2.86 Million	26,900 New	26,900 $2.49 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.